BATF3 and neoplasm: Batf3-dependent DCs cross-present tumour antigens and generate a baseline anti-tumour response that can be potentiated by immunostimulating antibodies in synergy with expansion and activation of this DC subset using Flt3L and poly I:C (refs 17, 18).